{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-009607","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.662375+00:00","generated_at":"2026-06-17T09:12:51.564704+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Pulmatrix reports FY2022 revenue $6.1M, net loss $18.8M; cash $35.6M into Q2 2024","bullets":["Revenue $6.1M (+$0.9M YoY); net loss $18.8M vs $20.2M; EPS -$5.46 vs -$8.63.","Cash $35.6M at Dec 31, 2022; runway into Q2 2024.","PUR1900 Phase 2b in ABPA dosed first patients in Q1 2023; topline data expected mid-2024.","PUR3100 Phase 1 for acute migraine positive: lower nausea vs IV DHE; plans for Phase 2.","PUR1800 Phase 1b data presented; analysis ongoing for potential Phase 2 study."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-009607","json":"https://secwatch.observer/filing/0001493152-23-009607.json","markdown":"https://secwatch.observer/filing/0001493152-23-009607.md","text":"https://secwatch.observer/filing/0001493152-23-009607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223009607/0001493152-23-009607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223009607/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:12:51.564704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8c49f2e491ca29a168681309b1669a9556a72568","claim":"Pulmatrix, Inc. reported the year ended December 31, 2022 results: revenue $6.1 million.","evidence_excerpt":"Revenue was $6.1 million for the year ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223009607/0001493152-23-009607-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$6.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}